Aducanumab

Discussion in 'BiogenIdec' started by anonymous, Apr 22, 2020 at 9:19 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Wonder what is really happening with this drug? Maybe not as far “along with the FDA” as described
     

  2. anonymous

    anonymous Guest

    My cousin works at McKinsey and tells me it is a mess...... not expecting approval ever on this
     
  3. anonymous

    anonymous Guest

    Ah ya think ?
    They’re not even submitting it to the FDA until either July August or September Q3 at earliest. If it gets submitted in that timeframe look for another six months for FDA to review the data. If approved maybe launch April 2021
     
  4. anonymous

    anonymous Guest

    If the data was clear, there wouldn’t be this much delay.

    COVID is an excuse. Do you really think it’s execs and VPs filling out the text and building out the data & charts?
     
  5. anonymous

    anonymous Guest

    Exactly the data is garbage. This drug is never going to get approved...and if it did payers aren't going to pay for this. It just doesn't work. Good pump for the stock up until today though!
     
  6. anonymous

    anonymous Guest

    they have hired already at least 50 people for this new medication.
     
  7. anonymous

    anonymous Guest

  8. anonymous

    anonymous Guest

    ya , earliest approval or launch if at
    all would be at sometime in 2021